(Press-News.org) Donor doping into a mother material with disordered intrinsic oxygen vacancies, instead of the widely used strategy of acceptor doping into a material without oxygen vacancies, can greatly enhance the conductivity and stability of perovskite-type proton conductors at intermediate and low temperatures of 250–400 °C, as demonstrated by Tokyo Tech scientists (e.g. 10 mS/cm at 320 °C). This innovative approach provides a new design direction for proton conductors for fuel cells and electrolysis cells.
Many countries in the world are pushing for the development of sustainable energy technologies. In this regard, protonic ceramic (or proton conducting) fuel/electrolysis cells (PCFCs/PCECs) are a strong contender. These devices can directly convert chemical energy into electricity and vice versa with zero emissions at low or intermediate temperatures, making them an attractive option for many emerging applications such as next-generation distributed power sources. In addition, unlike other types of fuel cells and electrolysers, the PCFCs/PCECs do not require precious metal catalysts or expensive, heat-resistant alloys.
However, there have been no reports of proton conductors with both high conductivity as well as high stability at intermediate and low temperatures of 250–400 °C. This problem is known as the “Norby gap,” and scientists have been searching for materials that can overcome it for many years.
Against this backdrop, Professor Masatomo Yashima and Mr. Kei Saito from Tokyo Institute of Technology (Tokyo Tech), Japan, have recently proposed a new strategy that could revolutionize the design and development of proton conductors. Their findings are published in the prestigious multidisciplinary journal Nature Communications.
The researchers tackled one of the main drawbacks of state-of-the-art perovskite-type proton conductors. These materials have the formula A2+B4+O3, where A and B are larger and smaller cations, respectively. A general strategy to enhance the proton conductivity in such perovskites is to introduce an acceptor dopant; that is, a cation M3+ with a valence lower than that of B4+. These “impurities” create oxygen vacancies in the resulting crystalline lattice, which, in turn, increases proton conductivity. However, this approach also creates a problem known as “proton trapping,” whereby protons are trapped by the acceptor dopant M3+, which has an effective negative charge relative to the host cation B4+, due to the electrostatic attraction.
To avoid this issue, the researchers turned to BaScO2.5. This perovskite has intrinsic (or inherent) oxygen vacancies in its crystal structure, which enables donor doping. The team doped donor dopant Mo6+ into BaScO2.5 to produce BaSc0.8Mo0.2O2.8 (or “BSM20”). “Contrary to the conventional acceptor doping approach, donor doping can reduce proton trapping effect through the electrostatic repulsion between protons and the donor Mo6+ cations, which have a higher valence than the host cation Sc3+,” explains Prof. Yashima. “This, in turn, leads to high proton conduction.”
Following a series of experiments and theoretical analyses using advanced simulation techniques, the researchers demonstrated that BSM20 indeed offered exceptionally high proton conductivity at intermediate and low temperatures in the Norby gap. Moreover, donor doping helped stabilize a cubic perovskite-type structure, enabling efficient three-dimensional proton conduction throughout the material. Notably, BSM20 also exhibited remarkably high stability under oxidizing, reducing, and carbon dioxide atmospheres, a property essential for many practical applications.
Overall, the findings of this study could pave the way for new proton conductors for PCFCs/PCECs with unprecedented performance. “The proposed strategies and the discovery of BSM20 could have a significant impact on energy and environmental science and technology,” concludes Prof. Yashima.
We, too, hope that these efforts will open doors to a greener future.
###
Yashima Research Group
About Tokyo Institute of Technology
Tokyo Tech stands at the forefront of research and higher education as the leading university for science and technology in Japan. Tokyo Tech researchers excel in fields ranging from materials science to biology, computer science, and physics. Founded in 1881, Tokyo Tech hosts over 10,000 undergraduate and graduate students per year, who develop into scientific leaders and some of the most sought-after engineers in industry. Embodying the Japanese philosophy of “monotsukuri,” meaning “technical ingenuity and innovation,” the Tokyo Tech community strives to contribute to society through high-impact research.
https://www.titech.ac.jp/english/
END
Saying "I'm sorry," especially in the workplace, can be tricky terrain. Delivering an effective apology can help resolve conflicts, restore trust and promote collaboration among coworkers.
But what works best?
A research team including a University of Arizona faculty member says that to make your next apology more effective, use language that goes against gender stereotypes.
Sarah Doyle, associate professor in the Department of Management and Organizations in the Eller College of Management, said the team wanted to ...
People with diabetes (Diabetes Mellitus) are two-to-three times more likely to have depression than people without, according to the Centers for Disease Control. Current treatment includes therapy, medicine, or both. However, the understanding of the multifaceted relationship between nutrition, mental health, and DM is relatively new in scientific discourse. Mason researchers sought to learn about the connection between nutrition, diabetes, and mental health.
Two literature reviews from assistant ...
A groundbreaking study recently published in JAMA indicates that aspirin may not be necessary as part of an antithrombotic regimen for patients with a fully magnetically levitated left ventricular assist device (LVAD). Ochsner Health surgical director for the Mechanical Assist Device Circulatory Support Program, Dr. Aditya Bansal, was a contributing author on the study known as the ARIES-HM3 trial.
The ARIES-HM3 trial, a randomized trial involving 628 patients with advanced heart failure, compared the outcomes of patients who received aspirin (100 mg/d) with those who received a placebo in addition to a vitamin K antagonist ...
Development of potential or improved anti-cancer treatments are being blocked or slowed down by lack of transparency in data sharing between pharmaceutical companies and research groups, according to cancer clinicians, researchers and consumers.
The multidisciplinary team led by Flinders University researchers Mr Natansh Modi and Dr Ashley Hopkins evaluates the literature and policy developments since the 2013 data sharing commitments were struck by US and European regulators, including the commitment to publish clinical trial results.
The agreement forged by the Pharmaceutical Research and Manufacturers ...
Perimenopausal women need better education and support about how their periods might change towards the end of their reproductive life, finds a new study led by UCL researchers.
The research, published in Post Reproductive Health, highlighted how as women approach the menopause, their periods may become unpredictable, heavy and cause worse premenstrual symptoms – including mood swings, breast tenderness and headaches.
The team of researchers from the UCL EGA Institute of Women’s Health and Centre for Reproductive Health, University of Edinburgh, ...
Key takeaways
UCLA psychologists used music to manipulate emotions of volunteers and found the dynamics of their emotions molded otherwise neutral experiences into memorable events.
The tug of war between integrating memories and separating them helps to form distinct memories, allowing people to understand and find meaning in their experiences, and retain information.
These findings could hold therapeutic promise in helping people with PTSD and depression.
Time flows in a continuous stream — yet our ...
CHAPEL HILL, N.C. – The Centers for Disease Control and Prevention report that autism is becoming more common in young children. In an effort to improve the challenges young autistic children face as part of their early development, researchers have focused on developing and evaluating nonpharmaceutical interventions that can be provided in early childhood.
Micheal Sandbank, PhD, an assistant professor in the Department of Health Sciences at the UNC School of Medicine, is an expert on the research supporting these early interventions, which informs clinical practice across the United States. A new comprehensive meta-analysis, led by Sandbank, shows that many low-quality ...
A new study from UCLA Health researchers demonstrates that a novel treatment is effective in most patients with major depressive symptoms even after multiple failed courses of antidepressant medication. The treatment, repetitive transcranial magnetic stimulation (rTMS), may work even more rapidly than past findings have suggested, starting to alleviate symptoms as quickly as one week.
Researchers from the Neuromodulation Division of UCLA’s Semel Institute analyzed the outcomes of hundreds of patients treated at UCLA Health from 2009 to 2022 with rTMS therapy, which uses magnetic fields to effectively “rewire” ...
Embargoed for release until 5:00 p.m. ET on Monday 20 November 2023
Annals of Internal Medicine Tip Sheet
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. ...
WASHINGTON, D.C. — More than 1,100 experts have joined the Physicians Committee for Responsible Medicine in boycotting the medical journal Nutrients until it stops publishing egregious animal experiments that could have been ethically conducted in humans.
The boycott, which also applies to Nutrients’ publisher, MDPI, comes after repeated requests to the journal’s editors asking them to institute sound editorial practices.
A letter sent to those editors today, Nov. 20, 2023, says “As a community of scientists and health care professionals, we have ...
